膜式血浆分离治疗性血浆置换的实践综述
本文综述了治疗性血浆置换中膜式血浆分离技术的原理与操作。膜式分离类似标准透析机的超滤过程,但膜孔径更大,可清除循环中大分子致病抗体和脂蛋白而保留细胞成分。与CRRT系统兼容的血浆分离膜使肾内科医生更易开展该治疗,文中介绍了美国可用的膜式技术、操作要点及可能并发症。
要点
- 膜式血浆分离可清除大分子致病抗体与脂蛋白并保留细胞成分
- 与CRRT系统兼容的血浆分离膜使肾内科医生更易开展血浆置换
- 需掌握膜式血浆置换的操作要点并识别其可能并发症
核心结论
- 治疗性血浆置换用于清除大分子量毒素如致病抗体和脂蛋白,膜式分离是可选方式之一。
研究设计与样本
- 综述,介绍美国可用的膜式血浆分离技术、血浆置换的处方与操作实践要点及可能并发症。
主要发现
- 离心式血浆置换在美国更常见,膜式分离在德国和日本更普及。
- 膜式分离类似标准透析机的超滤过程,但膜孔径大到可清除所有循环分子而保留细胞成分。
- 与CRRT系统兼容的血浆分离膜大幅提高了几乎全部肾内科医生开展此类治疗的可能性。
临床怎么用
- 肾内科医生可借助与CRRT系统兼容的血浆分离膜开展治疗性血浆置换,并按综述所述实践要点操作和防范并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Therapeutic plasma exchange is a blood purification technique designed for the removal of large molecular weight toxins such as pathogenic antibodies and lipoproteins. Plasma exchange can be performed either by membrane separation or centrifugation. Centrifugal plasma exchange is more common in the United States, while membrane separation is more popular in Germany and Japan. The membrane separation technique is similar to the ultrafiltration procedures performed with a standard dialysis machine but in which the membrane's pores are large enough to allow removal of all circulating molecules while retaining the cellular components. The current availability of plasma separation membranes compatible with CRRT systems has dramatically increased the potential for almost all nephrologists to perform these treatments. This review describes the membrane separation techniques available in the United States, the practical aspects of ordering and operating a membrane separation plasma exchange procedure, and its possible complications.
引用
- Ahmed S, Kaplan A. Therapeutic Plasma Exchange Using Membrane Plasma Separation. Clin J Am Soc Nephrol. 2020. PMID: 32312791. doi:10.2215/CJN.12501019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。